Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about MKGAF

Recent news which mentions MKGAF

Merck Germany's Two Pivotal Trials Flunk In Multiple Sclerosis
Tickers MKGAF MKKGY SNY
Tags Briefs SNY News
From Benzinga
Life Sciences Player Repligen's Strategic European Acquisition - What It Means for Investors
Tickers MKGAF MKKGY RGEN
Tags Health Care Trading Ideas Benzinga
From Benzinga
Merck Germany Reports 5% Decline In Q2 Sales, Expects More Decline In 2023
Tickers MKGAF MKKGY
Tags Guidance Market News Benzinga
From Benzinga
Novo Nordisk's Obesity Drug Saxenda Not Included In WHO's Essential Drug List
Tickers MKGAF MKKGY NVO REGN
Tags NVO MKGAF Benzinga
From Benzinga
Abcam Downgrade: Analyst Trims Expectations Amid Activist Investor Engagement and Potential Bid Anticipation
Tickers A ABCM DHR MKGAF
Tags General RVTY MKKGY
From Benzinga
Roche's Investigational Drug For Relapsing Multiple Sclerosis Reduces Brain Lesions, Data Shows
Tickers MKGAF RHHBF RHHBY RHHVF
Tags Briefs SNY News
From Benzinga
Analyst Says Nektar Therapeutics' Rezpeg Prioritization Likely to Spark Investor Questions
Tickers LLY MKGAF MKKGY NKTR
Tags Biotech NKTR Health Care
From Benzinga
FDA Issues Partial Clinical Hold On Merck Germany's Multiple Sclerosis Study
Tickers MKGAF MKKGY
Tags MKKGY General News
From Benzinga
Merck Germany Regains Exclusive Global Rights To Cancer Drug From Pfizer
Tickers M MKGAF MKKGY PFE
Tags MKKGY General News
From Benzinga
Incyte Would Now Compete With Merck, Pfizer As Its Skin Cancer Treatment Scores FDA Accelerated Approval
Tickers INCY MGNX MKGAF MKKGY
Tags Small Cap Biotech Large Cap
From Benzinga
PDS Biotech, Merck Germany Enter Licensing Pact For Investigational Cancer Treatment
Tickers MKGAF MKKGY PDSB
Tags News Briefs Movers
From Benzinga
Mersana Inks Cancer Therapy Development Deal With Merck Germany
Tickers MKGAF MKKGY MRSN
Tags Biotech Small Cap Eurasia
From Benzinga
GlaxoSmithKline, Merck KGaA End $4B Cancer Drug Pact
Tickers GSK MKGAF MKKGY MRK
Tags MKKGY General lung cancer
From Benzinga
Nektar, Merck Germany, Pfizer Join Forces For Mid-Stage Bladder Cancer Study
Tickers MKGAF MKKGY NKTR PFE
Tags General MKKGY Briefs
From Benzinga
Merck KGaA Pulls Plug On GSK-Partnered Cancer Drug Trial
Tickers GSK MKGAF MKKGY MRK
Tags News Briefs GSK
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.